Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Disposition to Issuer of 4,171,559 CPRX shares, $131.40M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to Issuer | 4,171,559 | $131.40M |
| Dec 30, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 26,334 | n/a |
| Dec 10, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 3,534 | n/a |
| Dec 3, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Gift | 45,000 | n/a |
| Nov 25, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,775 | n/a |
| Jun 10, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Sale | 28,252 | $733.0K |
| Dec 11, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 3,533 | n/a |
| Nov 25, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/Award | 43,591 | n/a |
| Nov 21, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 98,345 | $348.1K |
| Nov 15, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 92,500 | $327.4K |